Literature DB >> 24282903

Metastatic ovarian tumors: a clinicopathologic study of 150 cases.

Isabel Alvarado-Cabrero1, Adriana Rodríguez-Gómez, Jorge Castelan-Pedraza, Raquel Valencia-Cedillo.   

Abstract

OBJECTIVE: To determine the frequency of metastatic ovarian tumors and to identify their clinicopathologic features. STUDY
DESIGN: A total of 150 patients with pathologically confirmed metastatic ovarian carcinoma who were treated between 1995 and 2011 at the Mexican Oncology Hospital were identified by retrospective review. Clinicopathologic data were analyzed.
RESULTS: Metastatic ovarian carcinoma accounted for 15.7% of all ovarian malignancies. The primary sites of nongynecologic tumors were the colon (30%), stomach (16%), appendix (13%), breast (13%), pancreas (12%), biliary tract (15%), and liver (4%). Gynecologic primary sites were the uterine cervix (4%) and the uterine body (23%). Primary malignancies were detected first in 66 patients (44%) and simultaneously with ovarian metastasis in 53 patients (35.3%). An ovarian mass was the first manifestation of disease in 20.6% of the cases. The patients ranged in age from 26 to 72 years (mean, 51). Krukenberg tumors were found in 35 patients (23%). The cut surfaces of the ovaries were solid in 68 patients, solid-cystic in 38, and multicystic in 44.
CONCLUSION: Metastatic ovarian carcinomas are an important group of ovarian neoplasms, constituting 15.7% of all ovarian malignancies. Most of them arise from the gastrointestinal tract.

Entities:  

Mesh:

Year:  2013        PMID: 24282903

Source DB:  PubMed          Journal:  Anal Quant Cytopathol Histpathol        ISSN: 2578-742X


  9 in total

1.  Obstruction of the right stem bronchus due to ovarian local metastasis: a 5-year follow-up.

Authors:  Ilias Karapantzos; Paul Zarogoulidis; Michail Karanikas; Vasilis Thomaidis; Charalampos Charalampidis; Chrysa Karapantzou
Journal:  Ann Transl Med       Date:  2016-11

2.  Bilateral Ovarian Metastases from ALK Rearranged Non-Small Cell Lung Cancer.

Authors:  Kyung Ann Lee; Jong Sik Lee; Jae Ki Min; Hee Joung Kim; Wan Seop Kim; Kye Young Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-12-31

3.  Clinicopathological features and maternal and foetal management of pregnancy-complicating Krukenberg tumours.

Authors:  Jingjing Zhang; Peng Peng; Dongyan Cao; Jiaxin Yang; Keng Shen
Journal:  Mol Clin Oncol       Date:  2020-03-30

4.  Ovarian metastasis from breast cancer mimicking a primary ovarian neoplasm: A case report.

Authors:  Yoshika Akizawa; Toshiyuki Kanno; Yu Horibe; Yumi Shimizu; Eiichiro Noguchi; Tomoko Yamamoto; Takahiro Okamoto; Yoji Nagashima; Tsutomu Tabata
Journal:  Mol Clin Oncol       Date:  2021-05-17

Review 5.  The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review.

Authors:  Ondřej Kubeček; Jan Laco; Jiří Špaček; Jiří Petera; Jindřich Kopecký; Alena Kubečková; Stanislav Filip
Journal:  Clin Exp Metastasis       Date:  2017-07-20       Impact factor: 5.150

Review 6.  Molecular Alterations in Metastatic Ovarian Cancer From Gastrointestinal Cancer.

Authors:  Chao Chen; Xiaoxu Ge; Yamei Zhao; Da Wang; Limian Ling; Shu Zheng; Kefeng Ding; Jian Wang; Lifeng Sun
Journal:  Front Oncol       Date:  2020-12-10       Impact factor: 6.244

Review 7.  Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics.

Authors:  Pavel Dundr; Naveena Singh; Barbora Nožičková; Kristýna Němejcová; Michaela Bártů; Ivana Stružinská
Journal:  Diagn Pathol       Date:  2021-03-11       Impact factor: 2.644

8.  Ovarian metastases from ALK-positive lung adenocarcinoma: a case report and review of the literature.

Authors:  Huixin Li; Yan Chen; Yingchun Wang; Lin Zhou; Zhongfu Tian; Mengyu Liu; Yang Li; Hanzi Xu; Wangfei Wu; Zhen Gong
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

9.  Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report.

Authors:  Antonio De Leo; Margherita Nannini; Giulia Dondi; Donatella Santini; Milena Urbini; Elisa Gruppioni; Pierandrea De Iaco; Anna Myriam Perrone; Maria Abbondanza Pantaleo
Journal:  BMC Cancer       Date:  2018-03-16       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.